Celltrion
068270.KS
#824
Rank
โ‚น2.513 T
Marketcap
โ‚น11,174
Share price
0.22%
Change (1 day)
11.56%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Revenue for Celltrion (068270.KS)

Revenue in 2025 (TTM): โ‚น228.38 Billion

According to Celltrion 's latest financial reports the company's current revenue (TTM ) is โ‚น240.83 Billion. In 2024 the company made a revenue of โ‚น221.06 Billion an increase over the revenue in the year 2023 that were of โ‚น137.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Celltrion from 2008 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น228.38 B3.31%
2024 โ‚น221.06 B61.02%
2023 โ‚น137.29 B-5.42%
2022 โ‚น145.15 B18.21%
2021 โ‚น122.79 B5.28%
2020 โ‚น116.63 B68.51%
2019 โ‚น69.21 B10.86%
2018 โ‚น62.43 B14.86%
2017 โ‚น54.35 B37.51%
2016 โ‚น39.52 B13.33%
2015 โ‚น34.87 B22.32%
2014 โ‚น28.51 B122.81%
2013 โ‚น12.79 B-27.22%
2012 โ‚น17.58 B
2010 โ‚น7.04 B29.64%
2009 โ‚น5.43 B55.34%
2008 โ‚น3.49 B